Thalidomide-NH-amido-PEG4-C2-NH2 hydrochloride ole triol Its elimination half-life is 6

Its elimination half-life is 6

It was approved by the United States Food and Drug Administration (FDA) in November 2005

m-PEG7-Hydrazide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs

It can also cause a reduction in Aβ40 and Aβ42 levels in human primary neuronal cells (IC50 ~115 nM for total Aβ and ~200 nM for Aβ42) and in brain extracts

5-Methoxyflavone

Thalidomide-NH-amido-PEG4-C2-NH2 hydrochloride ole triol Its elimination half-life is 6Thalidomide NH amido PEG4 C2 NH2 hydrochloride is a synthesized E3 ligase ligand linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. Product information Molecular Weight: 586. 03 Formula: C25H36ClN5O9 Chemical Name: N (14 amino 3,6,9,12 tetraoxatetradecan 1 yl) 2 {[2 (2,6 dioxopiperidin 3 yl) 1,3 dioxo 2,3 dihydro 1H isoindol 4 yl]amino}acetamide; chlorohydrogen Smiles: Cl.